Objetivo
The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental validation of targets. The concept intends to bridge academic and applied research interests. The European Lead Factory will provide an industry-like small molecule discovery platform to public investigators. It builds on a unique, comprehensive, high-quality compound collection contributed by EFPIA Pparticipants, i.e. the Pharma Consortium Compound Collection totaling over about 300.000 compounds. Screening of these previously safeguarded corporate compound libraries against competitor’s targets and targets from public sources may result in otherwise inaccessible valuable lead structures that could ultimately result in the development of novel treatment options for patients. Academic Participantsa or other eligible bodies (and Contributing Third Parties) will be invited to submit proposals for screening of innovative targets and to suggest the design of new and diverse chemical libraries utilizing novel concepts and strategies. The latter will fuel the generation of a Public Compound Collection that will combine with the Pharma ConsortiumEFPIA Compound Collection to generate the Joint European Compound CollectionLibrary. These public sector contributions will not only provide a constant flow of innovation, but also generate opportunities for future partnerships amongst public Public Participants and private contributors EFPIA Participants on scientific and commercial grounds. EUC2LID’s overarching goal is value creation by screening the Joint European Compound Collection Library against in pPublic and private EFPIA Ttarget Programmes. Based on the successful delivery on its objectives during the IMI funding period, the generation of the high quality Public Compound Collection provides a tangible asset allowing the transition of the European Lead Factory into a novel sustainable business model, facilitating future public-private alliances based on pre-competitive, community-based efforts in early drug research.
Ámbito científico
Convocatoria de propuestas
IMI-JU-05-2012
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
51373 Leverkusen
Alemania
Ver en el mapa
Participantes (32)
2311 EZ Leiden
Ver en el mapa
La participación finalizó
ML1 5UH Newhouse
Ver en el mapa
5349 AB Oss
Ver en el mapa
OX1 2JD Oxford
Ver en el mapa
DD1 4HN Dundee
Ver en el mapa
44227 Dortmund
Ver en el mapa
6546BB Nijmegen
Ver en el mapa
44227 Dortmund
Ver en el mapa
69008 Lyon
Ver en el mapa
9747 AT Groningen
Ver en el mapa
NG1 1GF Nottingham
Ver en el mapa
La participación finalizó
80333 Muenchen
Ver en el mapa
3521 AL Utrecht
Ver en el mapa
NG7 2RD Nottingham
Ver en el mapa
La participación finalizó
1066 CX Amsterdam
Ver en el mapa
45141 Essen
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa
80539 Munchen
Ver en el mapa
6525 XZ Nijmegen
Ver en el mapa
2800 Kongens Lyngby
Ver en el mapa
LS2 9JT Leeds
Ver en el mapa
9712CP Groningen
Ver en el mapa
2340 Beerse
Ver en el mapa
64293 Darmstadt
Ver en el mapa
151 85 Sodertaelje
Ver en el mapa
65929 Frankfurt Am Main
Ver en el mapa
1070 Bruxelles / Brussel
Ver en el mapa
2500 Valby
Ver en el mapa
1031 Budapest
Ver en el mapa
ML1 5UH Newhouse
Ver en el mapa
75008 Paris
Ver en el mapa
2333 ZA Leiden
Ver en el mapa